Cocrystal Pharma Inc. (COCP)

Q2 EPS: Transformational 12 Months Ahead

August 7, 2020
Report ID: 11632
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Cocrystal Pharma Inc.
Cocrystal Pharma Inc.
Healthcare
Biotechnology
Ticker
COCP
Current Price
$2
Market Cap
$20.3M
Price Target
Refer to Report
Volume
17.5K
52wk Range
$1.74 - $3.96
Related Research Reports
8/15/2023

2Q23 Reported With New Clinical Trials Ready To Begin
2Q23 Reported With New Clinical Trials Ready To Begin (COCP)
5/15/2023

Products Are Advancing Toward Clinical Milestones
Products Are Advancing Toward Clinical Milestones (COCP)
3/30/2023

FY2022 Reported With New Clinical Trials On Track
FY2022 Reported With New Clinical Trials On Track (COCP)
12/20/2022

Safety and Tolerability Data From Influenza Study Announced
Safety and Tolerability Data From Influenza Study Announced (COCP)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.